JPRN-UMIN000024209招募中2 期
The therapeutic effect ofTemozolomide, Vincristine, Interferon-beta and Bevacizumab Combination Chemoradiotherapy for Malignant Gliomas - The therapeutic effect of Temozolomide, Vincristine, Interferon-beta and Bevacizumab Combination Chemoradiotherapy for Malignant Gliomas
Department of Neurosurgery, Hirosaki University Graduate school of Medicine0 个研究点目标入组 50 人开始时间: 2016年10月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who did not satisfy inclusion criteria.
研究者
相似试验
已完成
2 期
Multicombination Therapy of Temozolomide, Vincristine, and Interferon-beta with Radiotherapy for Malignant GliomaJPRN-UMIN000040599Department of Neurosurgery, Hirosaki University School of Medicine50
已完成
不适用
Feasibility of standard therapy with temozolomide and radiotherapy combined with ketogenic diet in patients with glioblastoma multiformeGlioblastoma MultiformeNL-OMON40862Erasmus MC, Universitair Medisch Centrum Rotterdam15
已完成
不适用
Ketogenic diet as adiuvant treatment in adults with glioblastoma multiformeGlioblastoma Multiforme, ketogenic diet, feasbility, safety, adults, brain cancer, ketosisNL-OMON19917ErasmusMC12
招募中
2 期
Temozolomide as monotherapy for elderly and temozolomide sensitive glioblastomaglioblastomaJPRN-jRCTs031200438Tateishi Kensuke5
进行中（未招募）
1 期
Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated glioblastoma (IDHwt) patients +/- tumor treating fields (Optune)GlioblastomaCTIS2023-506998-35-00Vaestra Goetalandsregionen190